clindamycin phosphate: Clinical Trials

25 trials of clindamycin phosphate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 3 unknown, 2 active not recruiting, 2 terminated. 6 Phase 3, 6 Phase 4, 5 Phase 1, 5 Phase 2, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6
Phase 46Completed 3, Unknown 3
Phase 15Completed 5
Phase 25Completed 2, Terminated 2, Active not recruiting 1
Early Phase 12Active not recruiting 1, Completed 1
Not applicable1Completed 1

Follow clindamycin phosphate: new trials by email Literature Review of clindamycin phosphate trials Research Report on clindamycin phosphate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris
clindamycin phosphate, adapalene and benzoyl peroxide - Acne Vulgaris
CompletedBausch Health Americas, Inc.2002025-10-022026-09-09
A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.
Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2%, CABTREO Topical Gel, Placebo Control - Acne Vulgaris
Phase 1CompletedSun Pharmaceutical Industries, Inc.3822024-05-132024-11-05
Experience With Topical Acne Treatment
clindamycin phosphate 1.2%/adapalene 0.15%/BPO 3.1% gel, adapalene 0.3%/BPO 2.5% gel and compounded clindamycin phosphate 1.2% gel, Compounded BPO 2.5% gel, adapalene 0.1% gel, and compounded clindamycin phosphate 1.2% gel - Acne
Early Phase 1Active not recruitingWake Forest University Health Sciences722024-02-152025-12-24
Title of the Protocol: Combined Use of Vaginal Clindamycin Cream and Oral Metronidazole Versus Oral Metronidazole
Clindamycin Phosphate - Bacterial Vaginosis
Not applicableCompletedAin Shams Maternity Hospital1002024-01-102025-11-25
Vancomycin and Tobramycin Powder Use in Acute Open Fractures
Cephalosporin or clindamycin/vancomycin antibiotics.., Vancomycin and Tobramycin antibiotics. - Infections
Early Phase 1CompletedUniversity of Utah102023-03-272024-12-20
Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
Clindamycin Phosphate, Triamcinolone Acetonide - Glioblastoma, Recurrent Glioblastoma
Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center482020-07-092026-08-10
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris
Clindamycin Phosphate, Clindamycin Phosphate RLD, Placebos - Acne Vulgaris
Phase 1CompletedSun Pharmaceutical Industries, Inc.5502019-09-092025-04-10
Antibiotic Irrigations for Intra-Abdominal Drains
Gentamicin Sulfate Inj 20mg/2ml vial for injection, Clindamycin phosphate 6 mg/1ml for injection, Placebo - Abdominal Abscess
Phase 2TerminatedUniversity of Iowa22019-04-012026-09-03
Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis
Intravenous Antibacterial Agent, Oral Antibacterial Agent - Osteomyelitis
Phase 2TerminatedLoyola University302014-03-192018-07-19
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel, DUAC® Gel, Placebo - Acne Vulgaris
Phase 3CompletedZydus Lifesciences Limited8502013-11-012020-10-14
Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile
Clindamycin - Bacterial Infections, Obesity
Phase 1CompletedPhillip Brian Smith222013-06-012016-11-29
Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris
Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5%, Acanya® Gel, 1.2%/2.5%, Vehicle of test product - Acne Vulgaris
Phase 1CompletedSun Pharmaceutical Industries, Inc.12152012-11-012017-05-05
Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris
Clindamycin Phosphate / Benzoyl Peroxide Gel, Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5%, Placebo (Vehicle Gel) - Acne Vulgaris
Phase 3CompletedWatson Laboratories, Inc.7082012-07-012013-02-11
A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris
Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5%, Acanya Gel, Placebo of Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% product - Acne
Phase 3CompletedPadagis LLC11802012-02-012021-10-22
Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris
Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning with with tretinoin 0.05% gel in the evening - Acne Vulgaris
Phase 4UnknownZeichner, Joshua, M.D.202011-07-012011-10-07
A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne
clindamycin phosphate 1.2%/tretinoin 0.025% gel alone, clindamycin phosphate 1.2%/tretinoin 0.025% gel plus benzoyl peroxide 6% foaming cloths - Acne Vulgaris
Phase 4UnknownZeichner, Joshua, M.D.402011-07-012011-08-24
Efficacy & Safety of Clindamycin and Tretinoin in Acne
Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel - Acne
Phase 4UnknownCallender Center for Clinical Research302009-11-012010-05-20
A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris
Clindamycin 1%/Benzoyl Peroxide 5% and 0.1% tazarotene, clindamycin phosphate 1.2%/benzoyl peroxide 2.5% and 0.1% tazarotene - Acne Vulgaris
Phase 4CompletedStiefel, a GSK Company402009-10-012017-01-30
Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications
Clindamycin and BPO 5% gel, Clindamycin phosphate and benzoyl peroxide 2.5% gel. - Acne Vulgaris
Phase 4CompletedStiefel, a GSK Company362009-08-012017-03-31
Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris
clindamycin phosphate 1.2% and tretinoin 0.025%, clindamycin 1% gel, tretinoin 0.025% cream - Acne Vulgaris
Phase 4CompletedWake Forest University262009-03-012018-09-10

Showing 20 of 25. Sign in to see all of them.

Conditions studied

Acne Vulgaris (15)  ·  Vaginitis (2)  ·  Vaginosis, Bacterial (2)  ·  Abdominal Abscess (1)  ·  Bacterial Infections (1)  ·  Diabetes Mellitus (1)  ·  Glioblastoma (1)  ·  Hyperpigmentation (1)  ·  Infections (1)  ·  Obesity (1)  ·  Osteomyelitis (1)  ·  Recurrence (1)  ·  Rosacea (1)  ·  Vulvovaginitis (1)

Sponsors

Sun Pharmaceutical Industries, Inc. (3)  ·  Lumara Health, Inc. (2)  ·  Stiefel, a GSK Company (2)  ·  Zeichner, Joshua, M.D. (2)  ·  Ain Shams Maternity Hospital (1)  ·  Bausch Health Americas, Inc. (1)  ·  Callender Center for Clinical Research (1)  ·  Hadassah Medical Organization (1)  ·  Loyola University (1)  ·  Massachusetts General Hospital (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Padagis LLC (1)  ·  Phillip Brian Smith (1)  ·  Skaraborg Hospital (1)  ·  University of Iowa (1)

Countries

United States (17)  ·  India (3)  ·  Russia (2)  ·  Canada (1)  ·  Egypt (1)  ·  Israel (1)  ·  Puerto Rico (1)

Top investigators

Jim Joffrion (2)  ·  Natalie Yantovskiy (2)  ·  Alexa Kimball, MD, MPH (1)  ·  Alina Markova, MD (1)  ·  Arie Ingber, MD, Prof (1)  ·  Dr Dharmesh Domadia, M.D (1)  ·  Elka Touitou, PhD, Prof (1)  ·  John L Capicchioni (1)  ·  Justin Haller, M.D. (1)  ·  Kevin Watt, MD (1)  ·  Laila Aly Farid, Professor (1)  ·  Michael J Smith, MD (1)  ·  Michael Pinzur, M.D. (1)  ·  P. Brian Smith, MD, MHS, MPH (1)

Results publications

PMID 22395584, PMID 23513559, PMID 24949994, PMID 8517703